Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Fluzone in Infants 2 vs 6 Months
NCT00858468Phase 2Completed
- Sponsor
- Sanofi
- Start
- Apr 2005
- Primary completion
- Jun 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Fluzone Trivalent in influenza, sponsored by Sanofi. Started Apr 2005; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00858468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00858468.